Omega Healthcare Investors (OHI) EBIT (2009 - 2026)

Omega Healthcare Investors has disclosed EBIT across 16 years of filings, most recently posting $209.7 million for Q1 2026.

• EBIT for Q1 2026 came in at $209.7 million, up 25.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $882.3 million (up 29.81% YoY), and the FY2025 annual result was $839.5 million, up 30.66% from the prior year.
• EBIT came in at $209.7 million for Q1 2026 at Omega Healthcare Investors, down from $223.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $252.9 million in Q1 2022 to a low of $93.3 million in Q1 2023.
• The 5-year median for EBIT is $166.0 million (2024), against an average of $167.8 million.
• Across the five-year window, EBIT tumbled 63.12% in 2023 and surged 50.24% in 2025, its largest moves.
• Omega Healthcare Investors' EBIT stood at $106.5 million in 2022, then grew by 13.87% to $121.3 million in 2023, then jumped by 43.41% to $173.9 million in 2024, then increased by 28.27% to $223.0 million in 2025, then decreased by 5.99% to $209.7 million in 2026.
• The last three EBIT figures came in at $209.7 million (Q1 2026), $223.0 million (Q4 2025), and $249.5 million (Q3 2025), per Business Quant data.